SEER Q2 2024 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$101M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-23.4% YoY

Gross Profit

$229,0007.5% margin

Operating Income

-$27M-882.0% margin

Net Income

-$23M-743.8% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+0.2%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$407M

Total Liabilities

$42M

Stockholders' Equity

$365M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-23.4%
Gross Profit	$229,000	$923,000	-75.2%
Operating Income	-$27M	-$28M	+3.0%
Net Income	-$23M	-$23M	+2.5%